Povention Bio

Provention’s Teplizumab Can Delay Onset of Type 1 Diabetes, Trial Results Show
BioSpace
Mon, 06/10/19 - 04:26 pm
Povention Bio
clinical trials
type 1 diabetes
ADA
immunotherapy